Biology Reference
In-Depth Information
24. Wang B, Li S, Qi HH, Chowdhury D, Shi Y, Novina CD (2009) Distinct passenger strand and
mRNA cleavage activities of human Argonaute proteins. Nat Struct Mol Biol 16(12):
1259-1266
25. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T (2004) Human
Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell
15(2):185-197
26. Ameres SL, Martinez J, Schroeder R (2007) Molecular basis for target RNA recognition and
cleavage by human RISC. Cell 130(1):101-112
27. Wang HW, Noland C, Siridechadilok B, Taylor DW, Ma E, Felderer K et al (2009) Structural
insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol
16(11):1148-1153
28. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of
21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature
411(6836):494-498
29. Chang CI, Kim HA, Dua P, Kim S, Li CJ, Lee DK (2011) Structural diversity repertoire of
gene silencing small interfering RNAs. Nucleic Acid Ther 21(3):125-131
30. Kim DH, Behlke MA, Rose SD, Chang MS, Choi S, Rossi JJ (2005) Synthetic dsRNA Dicer
substrates enhance RNAi potency and efficacy. Nat Biotechnol 23(2):222-226
31. Rose SD, Kim DH, Amarzguioui M, Heidel JD, Collingwood MA, Davis ME et al (2005)
Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids
Res 33(13):4140-4156
32. Sano M, Sierant M, Miyagishi M, Nakanishi M, Takagi Y, Sutou S (2008) Effect of asym-
metric terminal structures of short RNA duplexes on the RNA interference activity and strand
selection. Nucleic Acids Res 36(18):5812-5821
33. Aza-Blanc P, Cooper CL, Wagner K, Batalov S, Deveraux QL, Cooke MP (2003) Identification
of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol Cell
12(3):627-637
34. Khvorova A, Reynolds A, Jayasena SD (2003) Functional siRNAs and miRNAs exhibit
strand bias. Cell 115(2):209-216
35. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the
assembly of the RNAi enzyme complex. Cell 115(2):199-208
36. Noland CL, Ma E, Doudna JA (2011) siRNA repositioning for guide strand selection by
human Dicer complexes. Mol Cell 43(1):110-121
37. Hefner E, Clark K, Whitman C, Behlke MA, Rose SD, Peek AS et al (2008) Increased
potency and longevity of gene silencing using validated Dicer substrates. J Biomol Tech
19(4):231-237
38. Eder PS, DeVine RJ, Dagle JM, Walder JA (1991) Substrate specificity and kinetics of deg-
radation of antisense oligonucleotides by a 3' exonuclease in plasma. Antisense Res Dev
1(2):141-151
39. Kurreck J (2003) Antisense technologies Improvement through novel chemical modifications.
Eur J Biochem 270(8):1628-1644
40. Behlke MA (2008) Chemical modification of siRNAs for in vivo use. Oligonucleotides
18(4):305-320
41. Gaglione M, Messere A (2010) Recent progress in chemically modified siRNAs. Mini Rev
Med Chem 10(7):578-595
42. Krieg AM, Stein CA (1995) Phosphorothioate oligodeoxynucleotides: antisense or anti-pro-
tein? Antisense Res Dev 5(4):241
43. Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, White MA et al (2003) RNA interference in
mammalian cells by chemically-modified RNA. Biochemistry 42(26):7967-7975
44. Amarzguioui M, Holen T, Babaie E, Prydz H (2003) Tolerance for mutations and chemical
modifications in a siRNA. Nucleic Acids Res 31(2):589-595
45. Chiu YL, Rana TM (2003) siRNA function in RNAi: a chemical modification analysis. RNA
9(9):1034-1048
Search WWH ::
Custom Search